Molecular Mechanism of Amyloid Aggregation
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Neurobiology and Clinical Neuroscience".
Deadline for manuscript submissions: 31 August 2024 | Viewed by 358
Special Issue Editor
Interests: amyloid aggregation; atomic force microscopy; vibrational/IR spectroscopy; AFM-IR; photothermal spectroscopy; high-speed AFM; amyloid beta; TDP-43; alpha-synuclein; amylin; amyloid structure
Special Issue Information
Dear Colleagues,
This Special Issue will primarily focus on the molecular mechanism of amyloid aggregation. A tremendous amount of research over the past couple of decades has generated a plethora of information. However, the molecular mechanism that generates aggregates at the initial phase of aggregation is still not understood in detail. Without the in-depth knowledge of these aggregates, which have been identified to be neurotoxic, it is challenging to develop any therapeutics to address the fatal neurodegenerative diseases. Emerging single molecular imaging and spectroscopic biophysical techniques are revealing a new structural and mechanistic understanding of amyloid aggregation that has not been seen previously. We cordially invite authors to submit original research for this Special Issue of Biomedicines.
Dr. Siddhartha Banerjee
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- amyloid aggregation
- amyloid structure
- kinetics
- oligomers
- toxicity
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
